Tomotake Okuma
Overview
Explore the profile of Tomotake Okuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Motoi T, Hirata M, Kukita Y, Satomi K, Tamura H, Adachi S, et al.
Mod Pathol
. 2023 Aug;
36(11):100317.
PMID: 37634866
Sarcomas with BCOR genetic alterations (BCOR-associated sarcomas) represent a recently recognized family of soft tissue and bone tumors characterized by BCOR fusion, BCOR internal tandem duplication, or YWHAE::NUTM2B fusion. Histologically,...
2.
Sugita S, Morita E, Fujiwara M, Okuma T, Hozumi T
World Neurosurg
. 2023 Jun;
174:238.
PMID: 37270218
No abstract available.
3.
Tanaka K, Machida R, Kawai A, Nakayama R, Tsukushi S, Asanuma K, et al.
Br J Cancer
. 2022 Jul;
127(8):1487-1496.
PMID: 35871234
Background: This randomised phase II/III trial aimed to determine whether perioperative chemotherapy with gemcitabine plus docetaxel (GD) is non-inferior to the standard Adriamycin plus ifosfamide (AI) in terms of overall...
4.
Sugita S, Morita E, Fujiwara M, Okuma T, Hozumi T
World Neurosurg
. 2022 Mar;
163:e156-e161.
PMID: 35338021
Background: Metastatic epidural spinal cord compression (MESCC) may lead to walking disability. The effect of regaining gait ability on the life expectancy of cancer patients is still unknown. To explore...
5.
Ito K, Hirai T, Yujiro N, Okuma T
Clin Exp Metastasis
. 2021 May;
38(4):425-427.
PMID: 34052935
No abstract available.
6.
Shibayama T, Makise N, Motoi T, Mori T, Hiraoka N, Yonemori K, et al.
Am J Surg Pathol
. 2021 Mar;
45(5):616-626.
PMID: 33729740
Epithelioid hemangioendothelioma (EHE) is a rare vascular endothelial neoplasm with characteristic histology and distinctive fusion genes. Its clinical presentation and outcome are heterogeneous, and the determinants of survival are controversial....
7.
Kohsaka S, Hirata M, Ikegami M, Ueno T, Kojima S, Sakai T, et al.
Eur J Cancer
. 2021 Jan;
145:109-120.
PMID: 33444924
Previous studies have not clearly identified a prognostic factor for desmoid tumours (DT). Whole-exome sequencing (WES) and/or RNA sequencing (RNA-seq) were performed in 64 cases of DT to investigate the...
8.
Kobayashi H, Okuma T, Okajima K, Ishibashi Y, Zhang L, Hirai T, et al.
J Orthop Sci
. 2021 Jan;
27(1):222-228.
PMID: 33384219
Background: Eribulin is a tubulin and microtubule-targeting drug that has clinical benefit in overall survival (OS) for patients with advanced soft tissue sarcoma. Eribulin's efficacy has been confirmed in several...
9.
Suehara Y, Kohsaka S, Hayashi T, Akaike K, Kurisaki-Arakawa A, Sato S, et al.
Clin Orthop Relat Res
. 2020 Nov;
479(4):838-852.
PMID: 33196586
Background: Soft tissue sarcomas are a heterogeneous group of rare malignant tumors. Advanced soft tissue sarcomas have a poor prognosis, and effective systemic therapies have not been established. Tyrosine kinases...
10.
Nakamura T, Sugaya J, Naka N, Kobayashi H, Okuma T, Kunisada T, et al.
Cancer Manag Res
. 2020 Oct;
12:10017-10022.
PMID: 33116858
Background: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients...